Stocktoria
YD Bio Ltd YDES
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2025-08-29
Chart by TradingView
1/9
Piotroski F — financial health
-1.35
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Revenue | $596,817 | $510,360 |
| Gross profit | $167,410 | $155,356 |
| Operating income | -$5.3M | -$1.5M |
| Net income | -$8.3M | -$1.4M |
| Operating cash flow | -$6.6M | -$1.2M |
| Free cash flow | -$8.0M | -$1.3M |
| Total assets | $13.8M | $6.9M |
| Total liabilities | $16.6M | $273,980 |
| Shareholders' equity | -$2.9M | $6.6M |
| Ratios | ||
| Gross margin | 28.1% | 30.4% |
| Operating margin | -883.3% | -286.5% |
| Net margin | -1392.6% | -276.6% |
| FCF margin | -1346.6% | -254.3% |
| Return on assets | -60.3% | -20.6% |
| Return on equity | 291.0% | -21.4% |
| Current ratio | 5.88 | 13.18 |
| Revenue growth | 16.9% | — |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.35 (distress)
- Working capital / assets 0.583
- Retained earnings / assets -0.743
- EBIT / assets -0.383
- Equity / liabilities -0.172
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0002011674 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.